Calreticulin (CALR) mutation analysis

Lab Test name Contact Comments
UZ Brussel - Molecular Hematology Calreticulin (CALR) mutation analysis Marleen Bakkus/Christian Demanet
PCR on genomic DNA from blood or bone marrow followed by capillary electrophoresis. Ref: Klampfl et al. NEJM 2013; 369: 2379-90.
Version date: 26/09/2017
Accredited:
UZ Leuven MolPLUZ Calreticulin (CALR) mutation analysis Jolien De Bie
Sample type: blood / bone marrow (EDTA, 2-5 ml)
Frequency: 1x/week
Test type: PCR on DNA (ref: Klampf et al, NEJM 2013; exon 9)
BELAC accreditation number 215-MED
Accredited:
AZ St-Jan Brugge - Laboratoriumgeneeskunde Calreticulin (CALR) mutation analysis dr. Helena Devos/Friedel Nollet, Ph.D.
method : PCR and capillary electropheresis. Sensitivity 5%
Version date: 04/11/2017
Accredited:
LHUB-ULB Calreticulin (CALR) mutation analysis Pierre Heimann/Laurent Dewispelaere/Pascale Cochaux/Hakim El Housni
SAMPLE TYPE: Peripheral blood (5mL) or bone marrow (EDTA, 1-2 mL)
TRANSPORT: room temperature, within 24h after sampling
FREQUENCY: variable: max TAT: 4 weeks
TEST TYPE: CALR is analyzed in several in-house developed NGS panels designed to refine diagnosis and prognosis of MPN and MDS/MPN overlap syndrome.
BELAC accreditation number 650-MED
Version date: 04/10/2021
Accredited:
UZ Gent Calreticulin (CALR) mutation analysis Karl Vandepoele,
Joni Van Der Meulen,
Barbara Denys
In-house developed NGS panel to screen clinically relevant genes in MPN and MDS/MPN overlap:
CALR, JAK2 and MPL
BELAC accreditation number 087-MED

These genes are also present in the larger 68 genes NGS panel.
Version date: 16/03/2021
Accredited:
AZ Delta Calreticulin (CALR) mutation analysis Geert Martens, Elke Boone
SAMPLE TYPE: Blood or bone marrow (1ml, EDTA)
FREQUENCY: upon request
TEST TYPE: PCR & Fragment analysis (exon 9 indel),
Version date: 05/12/2017
Accredited: